BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
Authors
Keywords
-
Journal
Molecular Oncology
Volume 8, Issue 8, Pages 1429-1440
Publisher
Wiley
Online
2014-06-06
DOI
10.1016/j.molonc.2014.05.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Causes of Genome Instability
- (2013) Andrés Aguilera et al. Annual Review of Genetics
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations
- (2013) S. Bayraktar et al. CLINICAL & EXPERIMENTAL METASTASIS
- KISS1R Induces Invasiveness of Estrogen Receptor-Negative Human Mammary Epithelial and Breast Cancer Cells
- (2013) Donna Cvetković et al. ENDOCRINOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
- (2013) Mateusz Rytelewski et al. Molecular Therapy-Nucleic Acids
- Cancer treatment according to BRCA1 and BRCA2 mutations
- (2012) Kara N. Maxwell et al. Nature Reviews Clinical Oncology
- In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
- (2012) Jingli Hao et al. PLoS One
- Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
- (2011) P. M. L. H. Vencken et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Insight into the heterogeneity of breast cancer through next-generation sequencing
- (2011) Hege G. Russnes et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
- (2011) E Arpaia et al. ONCOGENE
- Real-Time Monitoring of Cisplatin-Induced Cell Death
- (2011) Hamed Alborzinia et al. PLoS One
- Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer
- (2010) Tomomi Egawa-Takata et al. CANCER SCIENCE
- The mutation spectrum revealed by paired genome sequences from a lung cancer patient
- (2010) William Lee et al. NATURE
- Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature
- (2009) Edward James et al. ANTI-CANCER DRUGS
- Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma
- (2009) W. Sakai et al. CANCER RESEARCH
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations
- (2008) Jeffrey T. Holt et al. CANCER GENETICS AND CYTOGENETICS
- Drug Resistance Caused by Reversion Mutation
- (2008) A. Ashworth CANCER RESEARCH
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started